Nuclear war fears as missile launch from North Korea causes people to 'take shelter'
A Twitter post sparked concern in Japan, although it soon became apparent the missile had passed over.
By CATHERINE MEYER-FUNNELL
00:15, Tue, Oct 4, 2022 | UPDATED: 00:15, Tue, Oct 4, 2022
https://www.express.co.uk/news/world/1677844/north-korea-kim-jong-un-missile-launch-japan-pacific-ocean-ont
https://twitter.com/BoKnowsNoga/status/1576781003325984769
SEPTEMBER 23, 2022
JUDICIAL WATCH
Judicial Watch: New Documents Reveal COVID-19 Vaccine Studies Used by HHS were Conducted in China
Updated 10/3/22
(Washington, DC) – Judicial Watch announced today that it received 115 pages of records from the Department of Health and Human Services (HHS) revealing previously redacted locations of COVID-19 vaccine testing facilities in Shanghai, China. The Food and Drug Administration (FDA) had claimed the name and location of the testing facilities were protected by the confidential commercial information exemption of the Freedom of Information Act (FOIA).
The records were obtained through a September 2021 FOIA lawsuit filed after the FDA, the Centers for Disease Control and Prevention and the National Institute for Allergy and Infectious Disease failed to respond to a June 7, 2021, FOIA request for all biodistribution studies and data for the COVID-19 vaccines (Judicial Watch v. U.S. Department of Health and Human Services (No. 1:21-cv-02418)).
The newly unredacted documents reveal the following Pfizer/BioNTech COVID-19 vaccine studies’ locations:
A document with the filename, “ s_r_IND 19736 0 105 2.6.5 pharmkintabulated-summary” identifies all in vitro metabolic stability studies of ALC-0315 and ALC-0159 (synthetic lipids in the vaccines) were conducted at Medicilon Preclinical Research LLC, a testing facility located in Shanghai, China.
A document with the filename, “s_r_IND 19736-0-253 Section 2.6.5 pharmkintabulated-summary” identifies that all in vitro metabolic stability studies of ALC-0315 and ALC-0159 were conducted at Medicilon Preclinical Research LLC, a testing facility located in Shanghai, China.
Additionally, Study 18350 was conducted at a Charles River testing facility in Tranent, UK
A document with the filename, “s_pharmkin-tabulated-summary.pdf” notes that all in vitro metabolic stability studies of ALC-0315 and ALC-0159 were conducted at Medicilon Preclinical Research LLC, a testing facility located in “Shanghai, China.”
The document adds that Study 18350 was conducted at a Charles River testing facility in Tranent, UK.
A document titled “FINAL REPORT” with the filename, “s_r_185350.pdf” and the logo, “Charles River” lists the TESTING FACILITY as “Charles River Laboratories Edinburgh Ltd. Elphinstone Research Centre Tranent, East Lothian EH33 2NE, UK”
“The Biden administration’s stonewalling and shell games about the COVID vaccines further undermine public confidence in these controversial drugs,” stated Judicial Watch President Tom Fitton. “Americans are now going to want to know why did the Biden operation try to hide COVID vaccine ties to China!”
https://www.judicialwatch.org/covid-vaccine-studies-conducted-in-china/